ANUH PHARMA LTD. has received a positive outlook revision from stable to positive for its credit ratings by ICRA Limited for various instruments including a long-term interchangeability rating of [ICRA]A- and a long-term/short-term bank guarantee of [ICRA]A-/[ICRA]A2+. This reflects the company's stable financial performance with an operating income rise to Rs. 647.0 crore in FY2024 and a PAT of Rs. 60.1 crore.